Company intelligence / Profile preview

Vengrowth Advanced Life Sciences Fund

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

The VenGrowth Advanced Life Sciences Fund was a Canadian venture capital fund focused on investing in late-stage life sciences companies. Managed by VenGrowth Asset Management, the fund targeted mature businesses within the biotechnology, pharmaceutical, and medical device sectors that were close to commercialization or already generating revenue. Its portfolio included notable Canadian biotech entities such as Arius Research and Middlebrook Pharmaceuticals. In 2011, following a period of restructuring and a contested merger process, the fund's assets were acquired by Covington Capital Corporation.

Industry: Investors

Beyond the preview

Go deeper on Vengrowth Advanced Life Sciences Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vengrowth Advanced Life Sciences Fund.

Explore the full profile